Assessing the Clinical Utility of CEA, CA 125 and CA 15.3 in Human Breast Carcinoma: A study among Tamil Women
A. Sheeba Christina1★★ Corresponding author
- 1Assistant Professor, Department of Biotechnology, PRISTUniversity (East campus), Yagappa Chavady, Thanjavur- 614 904. Tamil Nadu, INDIA.
CORRESPONDENCE
A. Sheeba Christina
Assistant Professor, Department of Biotechnology, PRISTUniversity (East campus), Yagappa Chavady, Thanjavur- 614 904. Tamil Nadu, INDIA.
Received: 12-04-2013; Revised: 22-04-2013; Accepted: 05-05-2013.
Volume 2, Issue 2 · pp. 107–110 · PUBLISHED 31 August 2013 · DOI:
ABSTRACT
Carcinoma of breast is a common disease that kills more number of women worldwide. Asensitive and specific serum marker would be of great help in early diagnosis of malignancy as well as in monitoring the response of cancer patients to therapy. The alterations in the serum level of 3 tumour markers namely, CEA, CA 125 and CA 15-3 at various stages of the disease were investigated in breast cancer patients of Tamil Nadu using Chemi Luminescence Immuno Assay (CLIA) method. The diagnostic significance of the markers were also analysed in three stages of disease namely, non-metastatic, metastatic and post-treatment levels. The results indicated increased levels of all the 3 tumour markers in breast cancer patients. Furthermore, marked elevation was found in patients with metastatic breast disease. Significant reduction was also observed in the post treatment level of CA 15.3. The findings suggest that among the 3 markers analysed, CA 15.3 is indeed helpful for early diagnosis and for predicting the disease response to therapy in breast cancer patients.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Christina, A. S. (2013). Assessing the Clinical Utility of CEA, CA 125 and CA 15.3 in Human Breast Carcinoma: A study among Tamil Women. Asian Journal of Biological and Life sciences, 2(2), 107–110.